Billy R. Ballard advances translational pathology across immunology and oncology, emphasizing biomarker discovery, monoclonal antibody and immunoassay development, and tissue-based diagnostics, with applications to inflammatory bowel disease, cancer dormancy, prostate signaling, and head and neck cancer detection.